ETFs
Mutual Funds
Home     |     Login     |    Contact Us    |    Product Literature
Market Cap
Style
Sector/Industry
International
Region
SPDR S&P Pharmaceuticals ETF (XPH)
Fund Objective Why was this benchmark selected?

The SPDR® S&P® Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry® Index (ticker: SPSIPHTR).  Our approach is designed to produce portfolios with low portfolio turnover, accurate tracking, and lower costs.

Ordinary brokerage commissions may apply.
  Market Price
  As of 11/26/2008
  Closing Price $27.28  
  Bid/Ask $27.34  
  Premium/Discount 0.85%  
  Day High $27.42  
  Day Low $26.36  
  Exchange Volume (shares) 8,403  
  Premium Discount to Nav Chart
  Net Asset Value
  As of 11/26/2008
  Price $27.39  
  Shares Outstanding 1,300,134  
  Total Net Assets $35,605,828.78  
  Most Recent NAV / NAV History
  Performance  
Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted.
  Fund Before Taxes      Fund After Taxes
Month End Performance
Total Return * Index Market Value NAV
  As of 10/31/2008 As of 10/31/2008 As of 10/31/2008
QTD -12.96%   -12.79%   -12.89%  
YTD -17.77%   -17.75%   -17.59%  
Annualized      
1 Year -19.32%   -19.14%   -19.19%  
3 Year N/A   N/A   N/A  
5 Year N/A   N/A   N/A  
Since Inception -4.19%   -4.37%   -4.39%  
Quarter End Performance
Total Return Index Market Value NAV
  As of 09/30/2008 As of 09/30/2008 As of 09/30/2008
QTD 1.86%   1.69%   1.83%  
YTD -5.53%   -5.69%   -5.40%  
Annualized      
1 Year -5.73%   -5.72%   -5.67%  
3 Year N/A   N/A   N/A  
5 Year N/A   N/A   N/A  
Since Inception 1.52%   1.36%   1.39%  
Fund Inception Date: 06/19/2006
Top Holdings ‡
As of 11/26/2008
Security Name Capitalization
($Million)		 Shares
Held		 Fund
Weight
Johnson & Johnson 161,674 29,101 4.76%
Pfizer Inc 108,359 109,798 4.96%
Abbott Labs 79,705 34,692 5.01%
Merck & Co Inc 55,624 63,968 4.73%
Wyeth 46,509 53,013 5.20%
Bristol Myers Squibb Co 40,721 96,988 5.61%
Lilly Eli & Co 37,372 43,623 4.03%
Schering Plough Corp 26,784 109,621 5.07%
Allergan Inc 11,193 34,709 3.59%
Barr Pharmaceuticals Inc 7,095 30,771 5.61%
View/Download All Holdings
  Top Sectors
  As of 11/26/2008
        View/Download All Holdings  
  Fund Characteristics
  As of 11/26/2008
  Dividend Yield 1.31%  
  FY1 P/E Ratio 11.49  
  Number of Holdings 23  
  Price/Book Ratio 2.06  
  Weighted Average Market Cap $M $29,406.62  
  Fund Information
  As of 11/28/2008
  Ticker Symbol XPH  
  CUSIP 78464A722  
  Marginable Yes  
  Short Selling Allowed Yes  
  Gross Expense Ratio 0.35%  
  Inception Date 06/19/2006  
  Primary Benchmark S&P Pharmaceuticals Select Industry Index  
  Investment Manager SSgA Funds Management, Inc.  
  Management Team ETF Management Team  
  Distributor State Street Global Markets, LLC  
  Distribution Frequency Quarterly  
  Fund Documents
  Quarterly Fund Fact Sheet (.pdf)
  Fund Prospectus (.pdf)
  Statement of Additional Information (.pdf)
  Fund Semi-Annual Report (.pdf)
  Fund Annual Report (.pdf)
To Top

‡ Subject to Change

§Performance numbers for funds less than 1 year old are cumulative. Performance periods under 1 year reflect performance for the fund and benchmark(s) from the fund's inception date to the month end shown above.

Index returns do not represent actual ETF performance and are for illustration purposes only. Index performance does not reflect charges and expenses associated with the fund or brokerage commissions associated with buying and selling exchange traded funds. It is not possible to invest directly in an index.

After-tax returns are calculated using the historical highest individual federal marginal income tax rates, and do not reflect the impact of state and local taxes. Actual after tax returns depend on the investor's tax situation and may differ from those shown, and the after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

After tax returns presented above may not take into account year end tax adjustments, which are calculated only at the end of each tax year. The after tax returns could differ after year end tax adjustments are accounted for.        

 Average annual total return and total return are historical and include change in share value and reinvestment of dividends and capital gains, if any.

Funds investing in a single sector may be subject to more volatility than funds investing in a dive